Get a glimpse into our company and investor data—powered by the PitchBook Platform
Prev ABR (Clostridium Difficile Infectious Disease Program)
Asset Purch.LATEST DEAL TYPE
Portfolio of biologic compounds in Maryland, United States. The portfolio comprises of a series of beta-lactamase compounds (P1A, P2A and P3A) to prevent and treat multidrug-resistant infectious diseases.